Integrative Oncology Scholars
Mission of the IO Scholars Program at the university of michigan
Our mission for the Integrative Oncology Scholars program is to develop a cohort of oncology professionals who have the knowledge and skills to provide the safe and evidence-based integration of complementary therapies in conventional oncology care, thereby helping to increase the safety and quality of life of cancer patients.
Our Training Objectives
The following are the three key training objectives of the IO Scholars Program:
- To learn how to evaluate the scientific evidence of complementary therapies used by cancer patients and survivors
- To facilitate the integration of evidence-based complementary therapies into oncology care
- To partner with community-based complementary medicine practitioners in order to reduce symptom burden, decrease distress and increase quality of life for cancer patients and survivors.
Our 2018-2019 cohort of io scholars
Our first cohort of Integrative Oncology Scholars began their training in August 2018. The cohort is comprised of 10 physicians from radiation, medical, and surgical oncology as well as primary care, dermatology, and palliative care; 5 advanced practice nurses; 5 social workers; three physician assistants; 1 pharmacist; and 1 physical therapist. Several of the social workers and nurses coordinate cancer survivorship programs at their institutions. IOS come from 13 states and the District of Columbia and represent 23 U.S. healthcare systems, including comprehensive cancer centers. See the states and institutions represented by our incredible 2018-2019 cohort and read a full overview of our training model in the Journal of Alternative and Complementary Medicine, September 2018.
History of Integrative Medicine at The University of Michigan
The Department of Family Medicine is also the home of the University of Michigan Integrative Family Medicine (IFM), an interdisciplinary program, which is committed to the thoughtful and compassionate integration of complementary therapies and conventional medicine through the activities of research, education, clinical services and community partnerships. IFM offers clinic services including holistic family medicine and anthroposophical medicine at their Domino’s Farm Family Practice site. Educational programs focused on Integrative Medicine are conducted in association with IFM include offerings on integrative medicine throughout the four years of the University of Michigan Medical School, a one year integrative family medicine fellowship now in its 12 year, and a year-long, multi-disciplinary Faculty Scholars Program in Integrative Medicine, which provides selected faculty from schools and colleges throughout the University of Michigan campus with an opportunity to explore the theoretical principles, clinical practices and evidence related to complementary alternative and integrative therapies.
IFM is actively associated with Integrative Medicine Research Faculty across the Campus, and was originally founded as the Complementary and Alternative Medicine Research Center (CAMRC) in 1998 by a Center grant from the then Office of Complementary and Alternative Medicine at the NIH. Dr. Zick one of the instructors and course director of the Integrative Oncology Scholars Program was an investigator on the CAMRC grant. IFM is also a member and actively involved in the Academic Consortium for Integrative Medicine and Health (ACIMH). The Consortium currently includes over 70 highly esteemed academic medical centers and affiliate institutions all of which have clinical, educational and research activities in Integrative medicine.
What is integrative oncology?
“Integrative oncology combines the discipline of modern science with the wisdom of traditional healing. It is an evolving evidence-based specialty that uses complementary therapies in concert with medical treatment to enhance its efficacy, improve symptom control, alleviate patient distress, and reduce suffering.” From "Integrative Oncology in North America" by Stephen Sagar in the Journal of the Society for Integrative Oncology. Winter 2006;4(1):27-39.